FDA advisers today will begin sketching out a long-term strategy for COVID vaccinations, addressing the risk of new variants and the need for new boosters.
Why it matters: Today's discussions could help lend clarity to a sometimes baffling vaccination effort that’s left many people unsure whether or when to shore up their immunity.
